University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 7 of 24
Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis
NCT04768777
VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
NCT06320951
Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilities
NCT07564934
Cue-Based Vs. Clinician-Driven Feeding in Very Low Birthweight Infants
NCT06569186
Mobile Thinking Intervention: A Inital Test
NCT06909422
Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation
NCT07535892
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
NCT07674745
Ketogenic Approach to Restore Muscle in Older Patients With Community-Acquired Pneumonia - KARMA-P Trial
NCT07308483
Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix
NCT07613047
Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain
NCT07682324
A Bundled Intervention to End Opioid Overdoses
NCT07485335
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
NCT07671937
Application to Predict Neonatal Apnea With Bradycardia
NCT06852053
Low-Dose Naltrexone For ME/CFS: Dose-Finding
NCT07285473
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
NCT07118592
Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament Reconstruction
NCT07605923
A Cognitive Mobile Intervention for Motivation in Psychotic Disorders
NCT07674914
Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis
NCT04670965
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
NCT06881888
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
NCT07307612
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
NCT07266571
Early Time-Restricted Eating for Cardiovascular Health
NCT07634926
TearCare in Young Adults
NCT07579156
Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma
NCT07521657
Passive Versus Active Music Therapy Parkinson's Disease
NCT07661524
Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area
NCT07570875
Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants
NCT07512245
Online Intervention To Improve Motivation
NCT07157293
False Vocal Fold vs EMG Guided Botox for Vocal Tremor
NCT07577310
To Compare the Two Implant Placement Protocols to Evaluate Placement Accuracy and Post-operative Healing of the Implant
NCT07512258
Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform
NCT07404189
Restoration of Knee Extension After ACL Reconstruction
NCT07685561
Evaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap Harvest
NCT07558096
The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
NCT06443177
Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood
NCT07446907
Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)
NCT06932640
Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors
NCT07501637
Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness
NCT07291778
Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.
NCT07457632
Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
NCT07475377
Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
NCT07611786
Abdominal aBscess Catheter Sclerotherapy (ABCS)
NCT06906029
Feasibility of Using NeuraSignal Transcranial Doppler Robot
NCT06565442
Yogic Breathing Exercise and Meditation for People With Spinal Cord Disorders
NCT07655531
Pilot Testing of Vagus Nerve Stimulation for Early Spinal Cord Injury Recovery
NCT07562113
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
NCT07523113
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
NCT05253131
AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions
NCT06950060
Comparison of Procedural Sedation in TEE
NCT06129188
Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy
NCT06309693
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.